Case Report
Zonisamide for Attenuation of Weight Gain in a Morbidly-Obese Adolescent on an Antipsychotic
Mathew L. Nguyen1, Michael A. Shapiro2* and Mariam Rahmani2 | |
1Assistant Professor, Division of Child and Adolescent Psychiatry, Department of Psychiatry, University of Florida, PO Box 100234, Gainesville, FL 32610, USA | |
2Department of Psychiatry, University of Florida, PO Box 100234, Gainesville, FL 32610, USA | |
Corresponding Author : | Dr. Michael A. Shapiro MD, Department of Psychiatry University of Florida, PO Box 100234, Gainesville, FL 32610, USA Tel: 352-870- 6234 Fax: 352-265-7053 E-mail: mshapiro@ufl.edu |
Received May 14, 2012; Accepted May 24, 2012; Published May 28, 2012 | |
Citation: Nguyen ML, Shapiro MA, Rahmani M (2012) Zonisamide for Attenuation of Weight Gain in a Morbidly-Obese Adolescent on an Antipsychotic. J Obes Wt Loss Ther 2:134. doi:10.4172/2165-7904.1000134 | |
Copyright: © 2012 Nguyen ML , et al . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited |
Abstract
Obesity is a growing problem in the child and adolescent population. Particularly concerning is the trend of overweight children being increasingly prescribed antipsychotic medications that can lead to further weight gain. We present a case of a morbidly obese adolescent male who had made strides in weight loss with psychopharmacologic aide who was started on an antipsychotic. Weight loss plateaued, and zonisamide was added to further help with weight loss. We discuss the possible risks and benefits of this medication in aiding in preventing weight gain associated with antipsychotic medication.